Somatilaka BN, Sadek A, Mckay RM, Le LQ (2022) Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene 41:2405–2421. https://doi.org/10.1038/s41388-022-02290-1
Article PubMed PubMed Central CAS Google Scholar
Mccarthy AJ, Karamchandani DM, Chetty R (2018) Neural and neurogenic tumours of the gastroenteropancreaticobiliary tract. J Clin Pathol 71:565–578. https://doi.org/10.1136/jclinpath-2017-204895
Article PubMed CAS Google Scholar
Malaguarnera G, Madeddu R, Catania VE, Bertino G, Morelli L, Perrotta RE, Drago F, Malaguarnera M, Latteri S (2018) Anorectal mucosal melanoma. Oncotarget 9:8785–8800. https://doi.org/10.18632/oncotarget.23835
Paolino G, Didona D, Macrì G, Calvieri S, Mercuri SR (2018) Anorectal melanoma. Exon Publications https://doi.org/10.15586/codon.noncutaneousmelanoma.2018.ch6
Kumada K, Ohhigashi S, Nishio T, Sakurai K (1996) A case of malignant schwannoma of anal canal. Nippon Daicho Komonbyo Gakkai Zasshi 49:1060–1064. https://doi.org/10.3862/jcoloproctology.49.1060
Yoshida H, Egami K, Wada M, Maeda S, Tanaka N, Onda M (1997) A case report of malignant schwannoma of the rectum. Jpn J Gastroenterol Surg Nihon Shokaki Geka Gakkai Zasshi 30:1809–1813. https://doi.org/10.5833/jjgs.30.1809
Fujii M, Tanaka Y, Saito T (2006) A case of malignant peripheral nerve sheath tumor of the rectum. Nippon Daicho Komonbyo Gakkai Zasshi 59:395–398. https://doi.org/10.3862/jcoloproctology.59.395
Matsuda N, Kanaya Y, Jida M, Fujii T, Maruyama S, Hirai R (2017) A case of malignant peripheral nerve sheath tumor of the rectum treated by laparoscopic surgery. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 78:1584–1589. https://doi.org/10.3919/jjsa.78.1584
Patra S, Ayyanar P, Padhi S, Purkait S, Muduly DK, Samal SC (2019) Epithelioid malignant peripheral nerve sheath tumor (epithelioid-MPNST) presenting as bleeding rectal polyp: a case report with systematic literature review. Am J Case Rep 20:1175–1181. https://doi.org/10.12659/AJCR.916251
Yamamoto A, Matsuyama T, Hatano S, Chika N, Kumakura M, Sugino A, Ishikawa H, Ito T, Kumagai Y, Mochiki E, Masuda W (2022) A case of malignant peripheral nerve sheath tumor of the anus resected by robot assisted-APR. Gan To Kagaku Ryoho 49:1977–1979. https://doi.org/10.32388/svcb4v
Zou J, Luo P, Chen T, Qian B (2024) Rectal malignant peripheral nerve sheath tumor found after anal canal neurofibroma surgery: a rare case report. Asian J Surg 47:1435–1436. https://doi.org/10.1016/j.asjsur.2023.11.116
Japanese Society for Cancer of the Colon and Rectum (2019) Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3rd English edition [secondary publication]. J Anus Rectum Colon 3:175–195. https://doi.org/10.23922/jarc.2019-018
Davis LE, Shalin SC, Tackett AJ (2019) Current state of melanoma diagnosis and treatment. Cancer Biol Ther 20:1366–1379. https://doi.org/10.1080/15384047.2019.1640032
Article PubMed PubMed Central CAS Google Scholar
Chute DJ, Cousar JB, Mills SE (2006) Anorectal malignant melanoma: morphologic and immunohistochemical features. Am J Clin Pathol 126(1):93–100. https://doi.org/10.1309/DVWL-TV8F-FKC3-L80H
Gaspard M, Lamant L, Tournier E, Valentin T, Rochaix P, Terrier P, Ranchere-Vince D, Coindre JM, Filleron T, Le Guellec S (2018) Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma? Histopathology 73:969–982. https://doi.org/10.1111/his.13740
Hassan A, Pestana RC, Parkes A (2021) Systemic options for malignant peripheral nerve sheath tumors. Curr Treat Options Oncol 22:33. https://doi.org/10.1007/s11864-021-00830-7
Cai Z, Tang X, Liang H, Yang R, Yan T, Guo W (2020) Prognosis and risk factors for malignant peripheral nerve sheath tumor: a systematic review and meta-analysis. World J Surg Oncol 18:257. https://doi.org/10.1186/s12957-020-02036-x
Article PubMed PubMed Central Google Scholar
Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM (2011) Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Am J Clin Oncol 34:417–421. https://doi.org/10.1097/COC.0
Article PubMed CAS Google Scholar
Woll PJ, Reichardt P, Le Cesne A, Yang R, Yan T, Guo W (2012) Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 13:1045–1054. https://doi.org/10.1016/s1470-2045(12)70346-7
Article PubMed CAS Google Scholar
Gronchi A, Ferrari S, Quagliuolo V et al (2017) Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol 18:812–822. https://doi.org/10.1016/S1470-2045(17)30334-0
Article PubMed CAS Google Scholar
Judson I, Verweij J, Gelderblom H et al (2014) Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol 15:415–423. https://doi.org/10.1016/S1470-2045(14)70063-4
Article PubMed CAS Google Scholar
Sobczuk P, Teterycz P, Czarnecka AM, Świtaj T, Koseła-Paterczyk H, Kozak K, Falkowski S, Rutkowski P (2020) Systemic treatment for advanced and metastatic malignant peripheral nerve sheath tumors-a sarcoma reference center experience. J Clin Med 9:3157. https://doi.org/10.3390/jcm9103157
Article PubMed PubMed Central Google Scholar
Kroep JR, Ouali M, Gelderblom H, Le Cesne A, Dekker TJ, Van Glabbeke M, Hogendoorn PC, Hohenberger P (2011) First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study. Ann Oncol 22:207–214. https://doi.org/10.1093/annonc/mdq338
Article PubMed CAS Google Scholar
Nakashima H, Tsukushi S, Shido Y (2005) Malignant peripheral nerve sheath tumor of paravertebral region which partially responded to chemotherapy with ifosfamide carboplatin and etoposide; a case report. Clin Orthop Surg 56:779–782. https://doi.org/10.15106/J00764.2005249779
Kinebuchi Y, Noguchi W, Igawa Y, Nishizawa O (2005) Recurrent retroperitoneal malignant nerve sheath tumor associated with neurofibromatosis type 1 responding to carboplatin and etoposide combined chemotherapy. Int J Clin Oncol 10:353–356. https://doi.org/10.1007/s10147-005-0495-8
Steins MB, Serve H, Zühlsdorf M, Senninger N, Semik M, Berdel WE (2002) Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapy. Oncol Rep 9:627–630. https://doi.org/10.3892/or.9.3.627
Article PubMed CAS Google Scholar
Kösemehmetoğlu K, Özoğul E, Babaoğlu B et al (2017) Programmed death ligand 1 (PD-L1) expression in malignant mesenchymal tumors. Turk Patoloji Derg. 1(1):192–197. https://doi.org/10.5146/tjpath.2017.01395
Article PubMed CAS Google Scholar
Shurell E, Singh AS, Crompton JG et al (2016) Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes. Oncotarget 7(39):64300–64308. https://doi.org/10.18632/oncotarget.11734
Article PubMed PubMed Central Google Scholar
Larson K, Russ A, Arif-Tiwari H et al (2022) Pembrolizumab achieves a complete response in an NF-1 mutated, PD-L1 positive malignant peripheral nerve sheath tumor: a case report and review of the benchmarks. J Immunother 45(4):222–226. https://doi.org/10.1097/CJI.0000000000000410
Comments (0)